Guanhao Biotech Co Ltd

Guanhao Biotech Co., Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. Its offerings include dura repair patches (NormalGEN and GrandNeuro), the ThormalGEN surgical patch, the DermalGEN wound dressing, the IREAL breast patch, and the Youvision corneal graft, along with licensed intraocular lenses. The company also provides Biological dura and Type B dura spinal patches, Sterile Bio Wound Membrane, Ario Mesh, Thoracic Surgery Repair Diaphragm, and Cympic Benvimod Cream for psoriasis, as well as artificial lenses, medical instruments, and cell technology services. Its products are used in neurosurgery, thoracic and general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Founded in 1999, Guanhao Biotech is headquartered in Guangzhou, China.

300238.CS▲2

Guanhao Biotech's Non-Public Share Issuance Application Review Status Changed to Submitted for Registration

Guanhao Biotech's application for a non-public share issuance under the simplified procedure has had its review status changed to submitted for registration. The company plans to issue no more than 9.5401 million shares to specific investors, raising a total of 97.5 million yuan. The funds will be used for the industrialization project of biological dura mater repair materials, supplementing working capital, and repaying bank loans. The sponsor is Wanlian Securities.

300238.CS ▲

证券时报·25dRead more →